EndoForce Connector Study for Dialysis Graft Access
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is testing a new connector system (EndoForce) used during dialysis graft placement in people with kidney failure. Researchers want to make sure it works safely and effectively in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have end-stage renal disease (kidney failure) and need a special plastic tube (graft) placed in your arm to connect you to a dialysis machine.
- Your doctor can place the graft in your upper arm.
- You (or your legal guardian) understand what the study involves, agree to follow the dialysis schedule and study visits, and sign a consent form.
- You are not pregnant, and you are not already in another dialysis or blood vessel study (unless the study sponsor says it is okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new artificial graft device designed to create a reliable access point in your arm for hemodialysis if you have end-stage kidney disease. The graft connects an artery to a vein, allowing easier and safer blood flow during dialysis treatments.
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
This trial tests a new device called the Velocity pAVF System that creates a connection between a vein and artery in your arm for hemodialysis. If you need dialysis now or within the next 6 months, this could be a new option for you.
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
This trial tests a new graft (artificial blood vessel) placed in your upper arm to help you receive kidney dialysis. The graft connects an artery to a vein, creating a reliable access point for dialysis needles.
This study monitors how well the BD WavelinQ endoAVF device works after routine clinical use. It may help people who need a dialysis access fistula by sharing real-world safety and performance data.
Hear when a new End Stage Renal Disease (ESRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.